Liraglutide belongs to the class of glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs, which increase glucose-dependent insulin secretion and decrease in appropriate glucagon secretion
Well, if I take thiamine and the next day it looks like Im halfway through the basketball game when I wake up, thats a sign that something is out of whack in my body
It will come down to developing a strategy, then choosing what we think are the right targets, designing stable molecules, running the studies, and having the discipline to stop if its not working
These patterns suggest causes unrelated to hormonal changes, which require different treatment approaches
The inherent risk of an all comers development strategy for obesity therapies Most companies today are developing obesity therapies focused on a narrow set of clinical endpoints headlined by weight loss percentage (Figure 1)
Some states offer special hazardous waste collection events where sharps containers are accepted alongside electronics, paint, and other household hazardous materials